MedImpact Healthcare Systems, Inc., the nation’s largest independent provider of health solutions, technology, and pharmacy benefit management services, has announced the successful completion of the integration of Elixir Solutions. This strategic acquisition not only enhances MedImpact’s scale and expands its portfolio of solutions but also secures the jobs of over 1,000 employees previously at risk due to Rite Aid’s bankruptcy. It ensures continuity in prescription services for millions of Elixir members.
“We are now one company, and we are 100% focused on delivering bold clinical and technology solutions and lowering drug costs,” stated Zach Johnson, Chief Innovation Officer at MedImpact. “We are in the strongest position ever to offer healthcare payers a superior alternative to existing marketplace options.”
MedImpact currently serves more than 20 million members, processes over $40 billion in pharmacy transactions annually, and commits significant resources to innovation and growth. The acquisition of Elixir is part of MedImpact’s broader strategy to bolster its technological capabilities, particularly in managing specialty drug expenditures and improving member health.
Despite these advancements, MedImpact remains committed to its core principles. Unlike vertically integrated entities that mandate the use of their retail and mail-order services, MedImpact will uphold its pharmacy-neutral stance, providing clients with flexibility and choice. As an independent company, MedImpact prioritizes delivering cost savings to healthcare payers and consumers rather than maximizing profits for shareholders.
“With our strategic investments, financial stability, and innovative roadmap, our entire organization is enthusiastic about the future and the value we will bring to clients and consumers,” Johnson affirmed.
